Latest News
Most Popular on DTE Site
- Health ministry sets timeframe for keeping animals treated with antibiotics out of food chain
- Gujarat pollution board gets a makeover in efficiency 33
- Illegal GM cotton spreads across India
- India's genome saviours
- Auroville’s alternative galaxy 2
- In celebration of biodiversity 5
- CSE volunteer barred from filming public hearing for Ultratech cement plant
- Become iron woman, eat veggies
- Kicking up a stink 4
- Chaos in the iron age 4
- Environment ministry wants to restore night traffic through Bandipur tiger reserve 52
- A green facade 44
- Diesel: when bad policy makes for toxic hell 38
- Gujarat pollution board gets a makeover in efficiency 33
- What’s good insulation? 30
- How vulnerable are India's nuclear power plants to disaster 28
- Grand distraction called river interlinking 28
- Eat at your own risk 27
- Green energy takes toll on green cover 26
- Temporary solution, permanent jam 25
On Facebook
Malaria deaths
Ranbaxy launches new anti-malarial drug
Issue Date: Apr 26, 2012
The Indian drug manufacturing company Ranbaxy Laboratories Limited launched a new anti-malarial drug, Synriam on the occasion of World Malaria Day on April 25.
The drug, a combination of arterolane maleate 150 mg and piperaquine phosphate 750 mg, is now available in the market. An adult suffering from malaria will need only one tablet a day for three days. In case of other malaria medicines two to four tablets are required, twice daily for three or more days. The new drug regime will lead to better compliance, says Ranbaxy.
O
P
E
N
DTE Must Read
Is Narmada water being made to flow in Sabarmati not supplied to city of Ahmedabad? This has furthered the idea of river...
Hello,
I have been selling glass for commercial buildings talking about light, thermal/solar heat gain etc.etc..but I...
Dear Saxena ji,
Thank you for inquiry.
West facing windows can be a big source of heat, first measure which you...